Home » Topics » Science » New compound

New compound
RSS

Merck & Co. presents novel AD-specific tau monoclonal antibody, MAFT-0617

April 1, 2019

MR-35602, a novel triple-activity compound with promising activity in model of AD

April 1, 2019

FT-113 shows promising antitumor activity in preclinical models

March 29, 2019

Novel optimized allosteric SHP2 inhibitors that modulate MAPK signaling

March 29, 2019

Dual inhibitor of CKI-alpha and -delta can help to control circadian rhythms

March 28, 2019

Boronated analogues of pleuromutilins show promise for filarial infections in vivo

March 27, 2019

ONO-ST-468 suppresses excessive GH secretion in GHRH/arginine-induced GH hypersecretion model

March 27, 2019

BKM-1972 inhibits intraosseous growth of chemosensitive and chemoresistant prostate cancer

March 25, 2019

HSJ-633 prevents inflammation-induced preterm birth and fetal tissue injury in vivo

March 21, 2019

SunRegen Healthcare presents data on SRG-003 in monkeys with optic atrophy

March 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...